<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29515365</article-id>
<article-id pub-id-type="pmc">5826236</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00028</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Persistent Expression of Serotonin Receptor 5b Alters Breathing Behavior in Male MeCP2 Knockout Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vogelgesang</surname>
<given-names>Steffen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Niebert</surname>
<given-names>Marcus</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/253927/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bischoff</surname>
<given-names>Anne M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hülsmann</surname>
<given-names>Swen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/49530/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manzke</surname>
<given-names>Till</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>DFG-Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB), University of Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute of Neuro- and Sensory Physiology, University of Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<aff id="aff3"><sup>3</sup><institution>Clinic for Anesthesiology, University Medical Göttingen</institution>, <addr-line>Göttingen</addr-line>, <country>Germany</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Hansen Wang, University of Toronto, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Erhard Wischmeyer, University of Würzburg, Germany; Daniela Tropea, Trinity College, Dublin, Ireland; Nicoletta Landsberger, Università degli Studi di Milano, Italy</p>
</fn>
<corresp id="fn001">*Correspondence: Marcus Niebert <email xlink:type="simple">mnieber@gwdg.de</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors share senior authorship.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>28</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>1</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Vogelgesang, Niebert, Bischoff, Hülsmann and Manzke.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Vogelgesang, Niebert, Bischoff, Hülsmann and Manzke</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Mutations in the transcription factor methyl-CpG-binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome (RTT). Besides many other neurological problems, RTT patients show irregular breathing with recurrent apneas or breath-holdings. MeCP2-deficient mice, which recapitulate this breathing phenotype, show a dysregulated, persistent expression of G-protein-coupled serotonin receptor 5-ht<sub>5b</sub> (<italic>Htr5b</italic>) in the brainstem. To investigate whether the persistence of 5-ht<sub>5b</sub> expression is contributing to the respiratory phenotype, we crossbred MeCP2-deficient mice with 5-ht<sub>5b</sub>-deficient mice to generate double knockout mice (<italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup>). To compare respiration between wild type (WT), <italic>Mecp2<sup>−/y</sup></italic> and <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice, we used unrestrained whole-body plethysmography. While the breathing of MeCP2-deficient male mice (<italic>Mecp2<sup>−/y</sup></italic>) at postnatal day 40 is characterized by a slow breathing rate and the occurrence of prolonged respiratory pauses, we found that in MeCP2-deficient mice, which also lacked the 5-ht<sub>5b</sub> receptor, the breathing rate and the number of pauses were indistinguishable from WT mice. To test for a potential mechanism, we also analyzed if the known coupling of 5-ht<sub>5b</sub> receptors to G<sub>i</sub> proteins is altering second messenger signaling. Tissue cAMP levels in the medulla of <italic>Mecp2<sup>−/y</sup></italic> mice were decreased as compared to WT mice. In contrast, cAMP levels in <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice were indistinguishable from WT mice. Taken together, our data points towards a role of 5-ht<sub>5b</sub> receptors within the complex breathing phenotype of MeCP2-deficient mice.</p>
</abstract>
<kwd-group>
<kwd>Rett syndrome</kwd>
<kwd>MeCP2</kwd>
<kwd>GPCR</kwd>
<kwd>5-ht<sub>5b</sub> receptor</kwd>
<kwd>cAMP regulation</kwd>
<kwd>breathing disturbances</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source>
<award-id rid="cn001">Cluster of Excellence and DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="54"></ref-count>
<page-count count="7"></page-count>
<word-count count="5053"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>The neurodevelopmental Rett syndrome (RTT) occurs primarily in females with an incidence of 1:10,000 live births and presents as a delayed regression after 6–18 months of apparently normal development (Rett, <xref ref-type="bibr" rid="B47">1966</xref>; Julu et al., <xref ref-type="bibr" rid="B23">2001</xref>). The disturbances typically start with early autonomic dysfunctions, including breathing abnormalities that are considered a potential cause of sudden death (Kerr et al., <xref ref-type="bibr" rid="B26">1997</xref>). The progressed phenotype manifests with neurological symptoms such as stereotypic hand movements, seizures and mental retardation with loss of language skills. RTT is caused by nonsense, missense or frameshift mutations, as well as large deletions of the human X-chromosomal gene methyl-CpG-binding protein 2 (<italic>MECP2</italic>; Amir et al., <xref ref-type="bibr" rid="B3">1999</xref>; Philippe et al., <xref ref-type="bibr" rid="B43">2006</xref>), which encodes the transcription factor MeCP2. MeCP2 acts in a DNA-methylation-dependent manner by repressing or activating gene transcription (Lewis et al., <xref ref-type="bibr" rid="B29">1992</xref>; Nan et al., <xref ref-type="bibr" rid="B39">1997</xref>; Chahrour et al., <xref ref-type="bibr" rid="B10">2008</xref>). MeCP2 is considered to be important during brain development, it accumulates most abundantly in post-mitotic adult neurons, where it is thought to be indispensable for maturation and synaptogenesis (Kishi and Macklis, <xref ref-type="bibr" rid="B27">2005</xref>; Guy et al., <xref ref-type="bibr" rid="B17">2011</xref>).</p>
<p>Different types of breathing abnormalities are associated with defects of MeCP2. Female RTT patients show periods of hyperventilation alternating with prolonged periods of breath-holdings (Kerr and Julu, <xref ref-type="bibr" rid="B25">1999</xref>; Julu et al., <xref ref-type="bibr" rid="B23">2001</xref>). In contrast, male patients rather show hypoventilation, apneas and respiratory insufficiency soon after birth (Geerdink et al., <xref ref-type="bibr" rid="B15">2002</xref>; Kankirawatana et al., <xref ref-type="bibr" rid="B24">2006</xref>; Schüle et al., <xref ref-type="bibr" rid="B48">2008</xref>). The male <italic>Mecp2<sup>−/y</sup></italic> null mice, which are the original model to analyze the loss of MeCP2 in neurons, have a characteristic impairment of breathing (Guy et al., <xref ref-type="bibr" rid="B18">2001</xref>), which manifests as hypoventilation, with a reduced respiratory rate and minute ventilation together with a high number of apneas (Viemari et al., <xref ref-type="bibr" rid="B52">2005</xref>; Chao et al., <xref ref-type="bibr" rid="B11">2010</xref>; Wegener et al., <xref ref-type="bibr" rid="B54">2014</xref>). Currently, the ultimate cause of altered respiratory behavior is not yet known and might very well be different in male and female subjects. However, it is clear that breathing of MeCP2 deficient mice is influenced by many factors that include neurotransmitter systems like norepinephrine (Viemari et al., <xref ref-type="bibr" rid="B52">2005</xref>) or neurotrophic factors like BDNF (Li and Pozzo-Miller, <xref ref-type="bibr" rid="B30">2014</xref>) as well as cellular systems like glia cells (Lioy et al., <xref ref-type="bibr" rid="B31">2011</xref>; Delépine et al., <xref ref-type="bibr" rid="B12">2015</xref>) and inhibitory neurons (Hülsmann et al., <xref ref-type="bibr" rid="B19">2016</xref>).</p>
<p>When we previously investigated the serotonergic system, we found that the serotonin receptor 5-ht<sub>5b</sub> is heavily dysregulated in the brainstem of <italic>Mecp2<sup>−/y</sup></italic> mice (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>). Rodents have been shown to possess two functional 5-ht<sub>5</sub> receptor subtypes, 5-ht<sub>5a</sub> (Plassat et al., <xref ref-type="bibr" rid="B44">1992</xref>) and 5-ht<sub>5b</sub> (Matthes et al., <xref ref-type="bibr" rid="B35">1993</xref>). While their physiological role is unknown, both are expressed at low levels in several brain regions and appear to be restricted to neural tissue (Rees et al., <xref ref-type="bibr" rid="B45">1994</xref>). So far, we know that 5-ht<sub>5b</sub> is expressed as both a full length as well as a truncated protein that is retained in the endosomal compartment. Yet, it is still able to interact with proteins (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>), and therefore can potentially alter second messenger signaling and cAMP levels.</p>
<p>In wild type (WT) mice, the expression of 5-ht<sub>5b</sub> receptor gradually increases during early development, peaks around postnatal day 21 (P21) and is then down-regulated. In <italic>Mecp2<sup>−/y</sup></italic> mice, however, 5-ht<sub>5b</sub> expression remains elevated past P21 (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>). This developmental difference coincides with the appearance of the respiratory phenotype, which develops between P20 and P40 (Viemari et al., <xref ref-type="bibr" rid="B52">2005</xref>; Mesuret et al., <xref ref-type="bibr" rid="B37">2018</xref>).</p>
<p>To investigate the functional role of the persistent expression of 5-ht<sub>5b</sub> receptors <italic>in vivo</italic> we generated MeCP2-deficient mice that also lack the 5-ht<sub>5b</sub> receptor (<italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice). Since our goal was to investigate the role of 5-ht<sub>5b</sub>, we chose to limit our analysis to male <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup>
<italic>mice, because</italic> the breathing phenotype of female mice is less predictable due to the variable x-chromosomal inactivation (Johnson et al., <xref ref-type="bibr" rid="B21">2015</xref>). Moreover, female mice remain asymptomatic often for more than a year (Guy et al., <xref ref-type="bibr" rid="B18">2001</xref>; Wegener et al., <xref ref-type="bibr" rid="B54">2014</xref>). Using only male mice allowed us not only to analyze the effect of the 5-ht<sub>5b</sub> receptors on breathing but also to measure their impact on the cellular cAMP level in the medulla.</p>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Ethics Statement</title>
<p>The experimental procedures were performed in accordance with European Community (EU Directive 2010/63/EU for animal experiments) and National Institutes of Health guidelines for the care and use of laboratory animals. In accordance with the German Protection of Animals Act (TierSchG §4 Abs. 3) procedures were approved by the Animal Welfare Office of University Medical Center Gottingen (file number ID T12/18).</p>
</sec>
<sec id="s2-2">
<title>Animal Models</title>
<p>The knockout mouse model for RTT, strain B6.129P2(C)-Mecp2tm1-1Bird (Guy et al., <xref ref-type="bibr" rid="B18">2001</xref>; maintained on a C57BL/6J background) was purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Hemizygous mutant <italic>Mecp2<sup>−/y</sup></italic> males were generated by crossing heterozygous <italic>Mecp2</italic><sup>+/−</sup> females with C57BL/6J wild-type males. The genotyping was performed in accordance with The Jackson Laboratory genotyping protocols<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>.</p>
<p>The knockout mouse model for the 5-ht<sub>5b</sub> receptor, strain 129SvEvBrd (maintained on a 29/SvEv-C57BL/6 background) was obtained from Taconic Europe A/S (Tornbjergvej 40, Ejby, 4623 Lille Skensved, Denmark). <italic>Htr5b</italic> knockout mice were backcrossed into the C57BL/6 background for at least eight generations. <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup>-double-knockout mice were then generated by crossbreeding female <italic>Mecp2</italic><sup>+/−</sup>;<italic>Htr5b</italic><sup>+/−</sup> mice with male <italic>Mecp2<sup>+/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice.</p>
</sec>
<sec id="s2-3">
<title>Genotyping</title>
<p>Tissue samples were incubated in 25 mM NaOH/0.2 mM EDTA for 3 h at 65°C. After neutralization with an equal volume of 40 mM Tris/HCl pH 5.5, 1 μL was taken as a template for subsequent PCR. The primers used for the identification of <italic>Htr5b</italic>-genotype were: WT-for (5′-ctctgcagtcggtttgatg-3′), WT-rev (5′-gtagagtcaccacaagcac-3′), KO-for (5′-gcagcgcatcgccttctatc-3′), KO-rev (5′-gtgctgggattagaagtcc-3′). The primers used for the identification of the <italic>Mecp2</italic> genotype were: WT-for (5′-gaccccttgggactgaagtt-3′), KO-for (5′-ccatgcgataagcttgatga-3′) and WT-KO-rev (5′-ccaccctccagtttggttta-3′).</p>
</sec>
<sec id="s2-4">
<title>Unrestrained Whole-Body- Plethysmography</title>
<p>Ventilation was measured by unrestrained whole-body-plethysmography (Drorbaugh and Fenn, <xref ref-type="bibr" rid="B13">1955</xref>; Bartlett and Tenney, <xref ref-type="bibr" rid="B7">1970</xref>) in 40-day old mice (P40). Mice were placed in a custom-made acrylic glass chamber (300 ml) that was connected to a differential low-pressure transducer (model DP1 03, Validyne Engineering, Northridge, CA, USA). The second channel of the pressure transducer was connected to a reference chamber (300 ml). The signal from the pressure transducer was fed into a sine wave carrier demodulator (CD-15, Validyne Engineering). Animals could explore the chamber freely. For the analysis, pressure changes were band-pass filtered (1.5–500 Hz) and amplified (four times) before storing on an Apple-PC computer. For digitization (1 kHz sampling rate) an ITC-16 interface (InstruTECH/HEKA, Lambrecht) was used that was controlled by Axograph 4.8 software (Axon Instruments, Foster City, CA, USA). A bias flow of 150 ml/min was introduced using a Normocap<sup>®</sup> CO<sub>2</sub>-sensor (Datex, Instrumentarium Oy, Helsinki, Finland). Pressure changes were exported and converted to axon binary files and used for analysis. Breaths (Inspiratory flow peaks) from a period of 3 min after 12 min adaptation to the chamber were analyzed by the threshold search peak detection method of Axon Clampfit (Molecular Devices, Sunnyvale, CA, USA). We did not discriminate between respiratory cycles associated to different types of behavior e.g., sniffing. Breathing frequencies were calculated as the reciprocal of the averaged inspiratory peak interval. The number of intervals between inspiratory peaks that were longer than 1 s was determined during the 3 min as a parameter for central apneas (Stettner et al., <xref ref-type="bibr" rid="B49">2008</xref>). To define the regularity of breathing, the coefficient of variation was calculated for the interval (CV = STD/mean) as well as an irregularity score (IS) was calculated: IS = 100*ABS[(Int<sub>n</sub> − Int<sub>n-1</sub>)/Int<sub>n-1</sub>] for each respiratory cycle (Barthe and Clarac, <xref ref-type="bibr" rid="B6">1997</xref>; Telgkamp et al., <xref ref-type="bibr" rid="B50">2002</xref>).</p>
</sec>
<sec id="s2-5">
<title>Measurement of cAMP</title>
<p>The cAMP concentration of murine tissue was determined using commercially available ELISA-based DetectX-kit (Arbor Assays) and performed according to manufacturer’s instructions. Absorbance was measured at 450 nm using Infinite 200 Pro reader (TECAN). Whole brains were explanted from 40 days old mice, separated and individual regions snap-frozen in liquid nitrogen.</p>
</sec>
<sec id="s2-6">
<title>Statistics</title>
<p>The cAMP measurements and plethysmography were analyzed with non-parametric Kruskal-Wallis and subsequent Dunn’s <italic>post hoc</italic> test for multiple comparisons. The survival plots were analyzed using the log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon tests. Analyses were performed using GraphPad Prism version 5.0d for Mac OSX (GraphPad Software, San Diego, CA, USA). Differences were considered statistically significant at <italic>P</italic> &lt; 0.05. Data are presented as the mean ± standard error of the mean (SEM; <italic>n</italic> = number of experiments).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3-1">
<title>Effect of 5-ht<sub>5b</sub> Knockout <italic>in Vivo</italic></title>
<p><italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b<sup>−/−</sup></italic> mice were generated by crossbreeding female <italic>Mecp2<sup>+/−</sup></italic>; <italic>Htr5b</italic><sup>+/−</sup> mice with male <italic>Mecp<sup>2+/y</sup></italic>; <italic>Htr5b</italic><sup>−/−</sup> mice. To our knowledge, <italic>Htr5b</italic><sup>−/−</sup> mice have no observable phenotype (see <ext-link ext-link-type="uri" xlink:href="http://www.taconic.com">www.taconic.com</ext-link> and Mouse Genome Database, <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/marker/MGI:96284">http://www.informatics.jax.org/marker/MGI:96284</ext-link>). In our hands, the life span of <italic>Htr5b</italic><sup>−/−</sup> mice was normal and body weight at P40 (19.06 ± 1.12 g) was indistinguishable from WT mice (20.60 ± 0.56 g) of the same age. Unrestrained whole-body plethysmography at postnatal day 40 (P40) revealed that <italic>Htr5b</italic><sup>−/−</sup> mice were breathing normal, which is in line with the notion that 5-ht<sub>5b</sub>-receptors are downregulated and thus dispensable at this age (Figure <xref ref-type="fig" rid="F1">1A</xref>). Like WT mice (<italic>n</italic> = 9), <italic>Htr5b</italic><sup>−/−</sup> mice (<italic>n</italic> = 7) did not show long (longer than 1 s) breathing arrests (Figure <xref ref-type="fig" rid="F1">1B</xref>), which are typical for <italic>Mecp2<sup>−/y</sup></italic>, and both, breathing rate (WT 6.68 s<sup>−1</sup> ± 0.41 vs. <italic>Htr5b<sup>−/−</sup></italic> 6.69 s<sup>−1</sup> ± 0.36; n.s.; Figure <xref ref-type="fig" rid="F1">1C</xref>) and IS (WT 0.23 ± 0.03 vs. <italic>Htr5b</italic><sup>−/−</sup> 0.28 ± 0.02; n.s.; Figure <xref ref-type="fig" rid="F1">1D</xref>) were indistinguishable from WT.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Plethysmographic <italic>in vivo</italic> recordings. <bold>(A)</bold> Plethysmographic <italic>in vivo</italic> recordings of wild type (WT; <italic>n</italic> = 9), <italic>Htr5b</italic><sup>−/−</sup> (<italic>n</italic> = 7), <italic>Mecp2<sup>−/y</sup></italic> (<italic>n</italic> = 10) and <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> (<italic>n</italic> = 11) mice at postnatal day 40 (P40). Recordings revealed improved breathing in <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice, which was expressed by the <bold>(B)</bold> reduction of long (&gt;1 s) apneas, <bold>(C)</bold> respiratory frequency and <bold>(D)</bold> irregularity score (IS). Corresponding bar diagrams represent the mean value and standard error of the mean (SEM). Asterisks indicate significance (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01; Kruskal-Wallis test with Dunn’s multiple comparisons).</p>
</caption>
<graphic xlink:href="fnmol-11-00028-g0001"></graphic>
</fig>
</sec>
<sec id="s3-2">
<title>Breathing of Mecp2<sup>−/y</sup>;<italic>Htr5b</italic><sup>−/−</sup> Mice Lacks Respiratory Arrests</title>
<p>When comparing breathing of <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b<sup>−/−</sup></italic> mice (<italic>n</italic> = 11) with <italic>Mecp2<sup>−/y</sup></italic> mice (<italic>n</italic> = 10), we found significantly improved breathing parameters, yet no full rescue. Unrestrained whole-body plethysmography at P40 revealed a slow irregular breathing rate in <italic>Mecp2<sup>−/y</sup></italic> mice with a high number of breathing arrests (5.3 ± 2.6 per 180 s, Figure <xref ref-type="fig" rid="F1">1B</xref>), low respiratory rate (4.6 ± 0.36 s<sup>−1</sup>; Figure <xref ref-type="fig" rid="F1">1C</xref>) and high IS (0.46 ± 0.06; Figure <xref ref-type="fig" rid="F1">1D</xref>). However, the breathing rhythm of <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice was more stable with intermediate values between <italic>Htr5b</italic><sup>−/−</sup> (<italic>or</italic> WT) <italic>and Mecp2<sup>−/y</sup></italic> mice. <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice showed a significantly lower number of breathing arrests longer than 1 s (0.5 ± 0.4 per 180 s; Figure <xref ref-type="fig" rid="F1">1B</xref>), and a higher respiratory rate (6.23 ± 0.65 s<sup>−1</sup>; Figure <xref ref-type="fig" rid="F1">1C</xref>), and the IS (0.33 ± 0.03; Figure <xref ref-type="fig" rid="F1">1D</xref>) was indistinguishable from WT and <italic>Htr5b<sup>−/−</sup></italic> mice. Moreover, body weight of <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice (17.52 ± 0.75 g) was higher than age-matched <italic>Mecp2<sup>−/y</sup></italic> mice (12.31 g ± 0.8; <italic>p</italic> &lt; 0.001) but did not reach the level of WT and <italic>Htr5b</italic><sup>−/−</sup> mice. The life span of <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice was improved compared to <italic>Mecp2</italic><sup>−/y</sup> mice (median 80 vs. 40 days), however no <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> survived longer than 130 days (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b<sup>−/−</sup></italic> mice show improved survival. The survival plot of <italic>Mecp2<sup>−/y</sup></italic> (red; <italic>n</italic> = 37) vs. <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> (green; <italic>n</italic> = 21) mice revealed a significantly increased median lifespan of 40–80 days, respectively (<italic>p</italic> = 0.0058 (Mantel-Cox) or <italic>p</italic> &lt; 0.001 (Gehan-Breslow-Wilcoxon). WT and <italic>Htr5b</italic><sup>−/−</sup> mice showed no lethality in the timeframe indicated and were omitted for clarity.</p>
</caption>
<graphic xlink:href="fnmol-11-00028-g0002"></graphic>
</fig>
</sec>
<sec id="s3-3">
<title>5-ht<sub>5b</sub> Affects cAMP Levels in Brainstem</title>
<p>Since 5-ht<sub>5b</sub> receptors are highly expressed in the brainstem of MeCP2-deficient mice at P40 (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>) and 5-ht<sub>5b</sub> receptors are able to reduce cellular cAMP levels <italic>in vitro</italic> (Niebert et al., <xref ref-type="bibr" rid="B40">2017</xref>), we measured the cAMP concentration in medullary brainstem lysates. The cAMP concentration of <italic>Mecp2<sup>−/y</sup></italic> mice at P40 was significantly lower (73.49 ± 7.27%) when compared to WT mice (Figure <xref ref-type="fig" rid="F3">3</xref>), whose cAMP levels were set as 100%. This reduction is in line with previous reports of low cAMP in the brainstem of <italic>Mecp2<sup>−/y</sup></italic> mice (Mironov et al., <xref ref-type="bibr" rid="B38">2011</xref>). In agreement with the hypothesis of constitutive 5-ht<sub>5b</sub>-receptor signaling we found normal cellular cAMP in <italic>Mecp2<sup>−/y</sup></italic>; <italic>Htr5b</italic><sup>−/−</sup> mice (98.46 ± 6.34%; Figure <xref ref-type="fig" rid="F3">3</xref>). These data are in line with the concept that the constitutive activity of 5-ht<sub>5b</sub> is impairing cAMP signaling in <italic>Mecp2</italic><sup>−/y</sup> mice (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Effect of <italic>Htr5b</italic> expression on cAMP levels. cAMP concentration in brainstem tissue of WT (<italic>n</italic> = 5), <italic>Mecp2<sup>−/y</sup></italic> (<italic>n</italic> = 5) and <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> (<italic>n</italic> = 5) mice. The bar diagram illustrates the relative cAMP concentration ([cAMP]) in brainstem tissue at P40 of <italic>Mecp2<sup>−/y</sup></italic> knockout mice and <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> double knockout mice in comparison to WT mice at P40. Asterisks indicate significance (*<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01; Kruskal-Wallis test with Dunn’s multiple comparisons).</p>
</caption>
<graphic xlink:href="fnmol-11-00028-g0003"></graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The <italic>Mecp2<sup>−/y</sup></italic> mouse model of RTT shows a prominent respiratory phenotype that develops relatively late during postnatal development. At P40, breathing is more irregular and MeCP2-deficient mice show reduced respiratory rate and an increased number of longer breathing arrests (Janc et al., <xref ref-type="bibr" rid="B20">2016</xref>). At this age, 5-ht<sub>5b</sub> receptor expression in the medulla of <italic>Mecp2</italic><sup>−/y</sup> mice is still elevated while it drops to neonatal level in the WT littermates between P21 and P40 (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>). In the present study, we tried to test for a pathophysiological link between the persistence of the 5-ht<sub>5b</sub> receptor and the breathing disturbances using mouse genetics.</p>
<sec id="s4-1">
<title>Alteration of Neuromodulator Pathways</title>
<p>5-ht<sub>5b</sub> receptors are not targeted to the plasma membrane but to the endosomal compartment, where they can participate in signaling by binding to G<sub>i</sub> proteins (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>) and lowering cAMP levels (Niebert et al., <xref ref-type="bibr" rid="B40">2017</xref>). Lower cAMP-levels in Mecp2<sup>−/y</sup> mice provide a simplistic rationale for the clinical use of cAMP-elevators like theophylline, as the “first choice for respiratory stimulation” in Rett patients (Julu et al., <xref ref-type="bibr" rid="B22">2008</xref>). In addition, the resulting imbalance of cAMP-dependent second messenger cascades is likely to affect not only the serotonergic system (Manzke et al., <xref ref-type="bibr" rid="B33">2003</xref>) but other neurotransmitters that have been implicated in the modulation of the respiratory network (Fujii et al., <xref ref-type="bibr" rid="B14">2004</xref>; Lalley, <xref ref-type="bibr" rid="B28">2008</xref>; Viemari, <xref ref-type="bibr" rid="B51">2008</xref>; Mellios et al., <xref ref-type="bibr" rid="B36">2014</xref>). In this respect, other effects on cAMP may seem contradictory: application of 5-HT<sub>1A</sub> receptor agonists, which reduces cAMP, has been reported to have positive effects on respiration in a Rett mouse model (Abdala et al., <xref ref-type="bibr" rid="B1">2010</xref>, <xref ref-type="bibr" rid="B2">2014</xref>) and patients (Andaku et al., <xref ref-type="bibr" rid="B4">2005</xref>; Ohno et al., <xref ref-type="bibr" rid="B41">2016</xref>). However, interactions between different neuromodulator pathways are manifold and even two G<sub>i</sub>-mediated pathways can be antagonistic if restricted to different cellular compartments or located in distinct types of neurons (Manzke et al., <xref ref-type="bibr" rid="B34">2010</xref>). Additionally, 5-HT<sub>1A</sub> receptors can modulate neuronal activity independently from cAMP, e.g., by modulating potassium currents (Penington et al., <xref ref-type="bibr" rid="B42">1993</xref>). Although we found a net reduction of cAMP in the medulla, we cannot rule out an additional effect of the 5-ht<sub>5b</sub> dependent reduction of 5-HT<sub>1A</sub> receptor surface expression (Niebert et al., <xref ref-type="bibr" rid="B40">2017</xref>). However, this mechanism appears rather unlikely to be of major importance, since 5-HT<sub>1A</sub> knockout mice have only a mild respiratory phenotype (Barrett et al., <xref ref-type="bibr" rid="B5">2012</xref>). Moreover, 5-HT<sub>1A</sub> receptor agonists have diverse effects including an anxiolytic action that, in the light of a potential role of the anxiety level of <italic>Mecp2<sup>−/y</sup></italic> mice (Ren et al., <xref ref-type="bibr" rid="B46">2012</xref>), might influence respiratory rhythm without directly influencing respiratory neurons.</p>
</sec>
<sec id="s4-2">
<title>Survival Is Still Impaired</title>
<p>The fact that the improvement of breathing does not completely rescue the life expectancy of the mice is, although disappointing, in line with earlier observations, as for the restoration of MeCP2 in inhibitory neurons (Hülsmann et al., <xref ref-type="bibr" rid="B19">2016</xref>). In <italic>Mecp2<sup>−/y</sup>;<italic>Htr5b</italic><sup>−/−</sup></italic> double-knockout mice, body weight was still reduced compared to WT and <italic>Htr5b<sup>−/−</sup></italic> mice and, although increased, the lifespan of <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> double-knockout mice was still significantly shorter than the lifespan of WT mice. Since we did not find a dysregulation of the 5-ht<sub>5b</sub>-receptor expression in the hippocampus (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>), any hippocampal pathology, which is e.g., involved in the increased propensity to seizures (Boison, <xref ref-type="bibr" rid="B9">2012</xref>), is not cured in <italic>Mecp2<sup>−/y</sup></italic>;<italic>Htr5b</italic><sup>−/−</sup> mice and, thus, can manifest later during the development of <italic>Mecp2<sup>−/y</sup></italic> mice leading to still premature death.</p>
</sec>
<sec id="s4-3">
<title>Translation to Human Rett Syndrome</title>
<p>Although the persistent expression of 5-ht<sub>5b</sub> contributes to the respiratory phenotype in MeCP2-deficient mice, these findings cannot be immediately translated to human patients. Unlike in mice (Grailhe et al., <xref ref-type="bibr" rid="B16">2001</xref>; Maekawa et al., <xref ref-type="bibr" rid="B32">2010</xref>; Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>), it is accepted that stop codons in the human <italic>HTR5B</italic> gene prevent its expression (Grailhe et al., <xref ref-type="bibr" rid="B16">2001</xref>). However, we found that 5-ht<sub>5b</sub> in mice is also expressed as a truncated protein (Vogelgesang et al., <xref ref-type="bibr" rid="B53">2017</xref>). As nothing is known about the expression and potential splice variants of 5-ht<sub>5b</sub> in humans, further analysis is required to identify potential alterations of 5-ht<sub>5b</sub> receptor expression in the brainstem of patients with MECP2 mutations.</p>
</sec>
<sec id="s4-4">
<title>Summary</title>
<p>MeCP2 deficiency affects several 100 targets (Ben-Shachar et al., <xref ref-type="bibr" rid="B8">2009</xref>) so any effect of 5-ht<sub>5b</sub>-receptor and cAMP signaling must be seen in the context of multiple other dysregulated genes. Our data supports the notion that 5-ht<sub>5b</sub>-receptor dysregulation is an important but probably not the only factor that contributes to respiratory problems in <italic>Mecp2<sup>−/y</sup></italic> mice. However, currently no data is available indicating a relevance of the 5-ht<sub>5b</sub> receptor expression in the pathology of human RTT patients.</p>
</sec>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>SV, AMB, TM and SH performed the experiments. TM, AMB, MN and SH analyzed the data. MN and SH wrote the manuscript.</p>
</sec>
<sec id="s7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>This work was supported by the Cluster of Excellence and Deutsche Forschungsgemeinschaft (DFG) Research Center Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). We acknowledge support by the Open Access Publication Funds of the Göttingen University. We are grateful to Anja-Annett Grützner for technical assistance. We are especially grateful to our mentor D.W. Richter for long and fruitful discussions that helped to improve the manuscript.</p>
</ack>
<fn-group>
<fn id="fn0001">
<p>
<sup>1</sup>
<ext-link ext-link-type="uri" xlink:href="http://jaxmice.jax.org/strain/003890.html">http://jaxmice.jax.org/strain/003890.html</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdala</surname><given-names>A. P. L.</given-names></name><name><surname>Dutschmann</surname><given-names>M.</given-names></name><name><surname>Bissonnette</surname><given-names>J. M.</given-names></name><name><surname>Paton</surname><given-names>J. F. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Correction of respiratory disorders in a mouse model of Rett syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>18208</fpage>–<lpage>18213</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1012104107</pub-id><pub-id pub-id-type="pmid">20921395</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdala</surname><given-names>A. P.</given-names></name><name><surname>Lioy</surname><given-names>D. T.</given-names></name><name><surname>Garg</surname><given-names>S. K.</given-names></name><name><surname>Knopp</surname><given-names>S. J.</given-names></name><name><surname>Paton</surname><given-names>J. F. R.</given-names></name><name><surname>Bissonnette</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome</article-title>. <source/>Am. J. Respir. Cell Mol. Biol.
<volume>50</volume>, <fpage>1031</fpage>–<lpage>1039</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2013-0372OC</pub-id><pub-id pub-id-type="pmid">24351104</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andaku</surname><given-names>D. K.</given-names></name><name><surname>Mercadante</surname><given-names>M. T.</given-names></name><name><surname>Schwartzman</surname><given-names>J. S.</given-names></name></person-group> (<year>2005</year>). <article-title>Buspirone in Rett syndrome respiratory dysfunction</article-title>. <source/>Brain Dev.
<volume>27</volume>, <fpage>437</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2004.09.011</pub-id><pub-id pub-id-type="pmid">15967617</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>K. T.</given-names></name><name><surname>Kinney</surname><given-names>H. C.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Daubenspeck</surname><given-names>J. A.</given-names></name><name><surname>Leiter</surname><given-names>J. C.</given-names></name><name><surname>Nattie</surname><given-names>E. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Subtle alterations in breathing and heart rate control in the 5-HT1A receptor knockout mouse in early postnatal development</article-title>. <source/>J. Appl. Physiol.
<volume>113</volume>, <fpage>1585</fpage>–<lpage>1593</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00939.2012</pub-id><pub-id pub-id-type="pmid">22936722</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barthe</surname><given-names>J. Y.</given-names></name><name><surname>Clarac</surname><given-names>F.</given-names></name></person-group> (<year>1997</year>). <article-title>Modulation of the spinal network for locomotion by substance P in the neonatal rat</article-title>. <source/>Exp. Brain Res.
<volume>115</volume>, <fpage>485</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1007/pl00005718</pub-id><pub-id pub-id-type="pmid">9262203</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>D. J.</given-names></name><name><surname>Tenney</surname><given-names>S. M.</given-names></name></person-group> (<year>1970</year>). <article-title>Control of breathing in experimental anemia</article-title>. <source/>Respir. Physiol.
<volume>10</volume>, <fpage>384</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/0034-5687(70)90056-3</pub-id><pub-id pub-id-type="pmid">5476156</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shachar</surname><given-names>S.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Thaller</surname><given-names>C.</given-names></name><name><surname>Shaw</surname><given-names>C. A.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Mouse models of MeCP<sub>2</sub> disorders share gene expression changes in the cerebellum and hypothalamus</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume>, <fpage>2431</fpage>–<lpage>2442</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp181</pub-id><pub-id pub-id-type="pmid">19369296</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boison</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Is intrinsic hyperexcitability in CA3 the culprit for seizures in Rett syndrome?</article-title>
<source/>Epilepsy Curr.
<volume>12</volume>, <fpage>13</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.5698/1535-7511-12.1.13</pub-id><pub-id pub-id-type="pmid">22368519</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>S. Y.</given-names></name><name><surname>Shaw</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Wong</surname><given-names>S. T. C.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>MeCP2, a key contributor to neurological disease, activates and represses transcription</article-title>. <source/>Science
<volume>320</volume>, <fpage>1224</fpage>–<lpage>1229</lpage>. <pub-id pub-id-type="doi">10.1126/science.1153252</pub-id><pub-id pub-id-type="pmid">18511691</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H.-T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>. <source/>Nature
<volume>468</volume>, <fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id><pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delépine</surname><given-names>C.</given-names></name><name><surname>Nectoux</surname><given-names>J.</given-names></name><name><surname>Letourneur</surname><given-names>F.</given-names></name><name><surname>Baud</surname><given-names>V.</given-names></name><name><surname>Chelly</surname><given-names>J.</given-names></name><name><surname>Billuart</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Astrocyte transcriptome from the Mecp2308-truncated mouse model of Rett syndrome</article-title>. <source/>Neuromolecular Med.
<volume>17</volume>, <fpage>353</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-015-8363-9</pub-id><pub-id pub-id-type="pmid">26208914</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drorbaugh</surname><given-names>J. E.</given-names></name><name><surname>Fenn</surname><given-names>W. O.</given-names></name></person-group> (<year>1955</year>). <article-title>A barometric method for measuring ventilation in newborn infants</article-title>. <source/>Pediatrics
<volume>16</volume>, <fpage>81</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="pmid">14394741</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M.</given-names></name><name><surname>Umezawa</surname><given-names>K.</given-names></name><name><surname>Arata</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Dopaminergic modulation on respiratory rhythm in rat brainstem-spinal cord preparation</article-title>. <source/>Neurosci. Res.
<volume>50</volume>, <fpage>355</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2004.07.009</pub-id><pub-id pub-id-type="pmid">15488298</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geerdink</surname><given-names>N.</given-names></name><name><surname>Rotteveel</surname><given-names>J. J.</given-names></name><name><surname>Lammens</surname><given-names>M.</given-names></name><name><surname>Sistermans</surname><given-names>E. A.</given-names></name><name><surname>Heikens</surname><given-names>G. T.</given-names></name><name><surname>Gabreëls</surname><given-names>F. J. M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>MECP2 mutation in a boy with severe neonatal encephalopathy: clinical, neuropathological and molecular findings</article-title>. <source/>Neuropediatrics
<volume>33</volume>, <fpage>33</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1055/s-2002-23598</pub-id><pub-id pub-id-type="pmid">11930274</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grailhe</surname><given-names>R.</given-names></name><name><surname>Grabtree</surname><given-names>G. W.</given-names></name><name><surname>Hen</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Human 5-HT<sub>5</sub> receptors: the 5-HT<sub>5A</sub> receptor is functional but the 5-HT<sub>5B</sub> receptor was lost during mammalian evolution</article-title>. <source/>Eur. J. Pharmacol.
<volume>418</volume>, <fpage>157</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-2999(01)00933-5</pub-id><pub-id pub-id-type="pmid">11343685</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Cheval</surname><given-names>H.</given-names></name><name><surname>Selfridge</surname><given-names>J.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of MeCP2 in the brain</article-title>. <source/>Annu. Rev. Cell Dev. Biol.
<volume>27</volume>, <fpage>631</fpage>–<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-cellbio-092910-154121</pub-id><pub-id pub-id-type="pmid">21721946</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guy</surname><given-names>J.</given-names></name><name><surname>Hendrich</surname><given-names>B.</given-names></name><name><surname>Holmes</surname><given-names>M.</given-names></name><name><surname>Martin</surname><given-names>J. E.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome</article-title>. <source/>Nat. Genet.
<volume>27</volume>, <fpage>322</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1038/85899</pub-id><pub-id pub-id-type="pmid">11242117</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hülsmann</surname><given-names>S.</given-names></name><name><surname>Mesuret</surname><given-names>G.</given-names></name><name><surname>Dannenberg</surname><given-names>J.</given-names></name><name><surname>Arnoldt</surname><given-names>M.</given-names></name><name><surname>Niebert</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>GlyT2-Dependent preservation of MECP2-expression in inhibitory neurons improves early respiratory symptoms but does not rescue survival in a mouse model of Rett syndrome</article-title>. <source/>Front. Physiol.
<volume>7</volume>:<fpage>385</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00385</pub-id><pub-id pub-id-type="pmid">27672368</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janc</surname><given-names>O. A.</given-names></name><name><surname>Hüser</surname><given-names>M. A.</given-names></name><name><surname>Dietrich</surname><given-names>K.</given-names></name><name><surname>Kempkes</surname><given-names>B.</given-names></name><name><surname>Menzfeld</surname><given-names>C.</given-names></name><name><surname>Hülsmann</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Systemic radical scavenger treatment of a mouse model of rett syndrome: merits and limitations of the vitamin E derivative trolox</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>:<fpage>266</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2016.00266</pub-id><pub-id pub-id-type="pmid">27895554</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>C. M.</given-names></name><name><surname>Cui</surname><given-names>N.</given-names></name><name><surname>Zhong</surname><given-names>W.</given-names></name><name><surname>Oginsky</surname><given-names>M. F.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Breathing abnormalities in a female mouse model of Rett syndrome</article-title>. <source/>J. Physiol. Sci.
<volume>65</volume>, <fpage>451</fpage>–<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1007/s12576-015-0384-5</pub-id><pub-id pub-id-type="pmid">26071253</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julu</surname><given-names>P. O.</given-names></name><name><surname>Engerström</surname><given-names>I. W.</given-names></name><name><surname>Hansen</surname><given-names>S.</given-names></name><name><surname>Apartopoulos</surname><given-names>F.</given-names></name><name><surname>Engerstrom</surname><given-names>B.</given-names></name><name><surname>Pini</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Cardiorespiratory challenges in Rett’s syndrome</article-title>. <source/>Lancet
<volume>371</volume>, <fpage>1981</fpage>–<lpage>1983</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(08)60849-1</pub-id><pub-id pub-id-type="pmid">18555901</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julu</surname><given-names>P. O.</given-names></name><name><surname>Kerr</surname><given-names>A. M.</given-names></name><name><surname>Apartopoulos</surname><given-names>F.</given-names></name><name><surname>Al-Rawas</surname><given-names>S.</given-names></name><name><surname>Engerström</surname><given-names>I. W.</given-names></name><name><surname>Engerström</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder</article-title>. <source/>Arch. Dis. Child.
<volume>85</volume>, <fpage>29</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1136/adc.85.1.29</pub-id><pub-id pub-id-type="pmid">11420195</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kankirawatana</surname><given-names>P.</given-names></name><name><surname>Leonard</surname><given-names>H.</given-names></name><name><surname>Ellaway</surname><given-names>C.</given-names></name><name><surname>Scurlock</surname><given-names>J.</given-names></name><name><surname>Mansour</surname><given-names>A.</given-names></name><name><surname>Makris</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Early progressive encephalopathy in boys and MECP2 mutations</article-title>. <source/>Neurology
<volume>67</volume>, <fpage>164</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000223318.28938.45</pub-id><pub-id pub-id-type="pmid">16832102</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>A. M.</given-names></name><name><surname>Armstrong</surname><given-names>D. D.</given-names></name><name><surname>Prescott</surname><given-names>R. J.</given-names></name><name><surname>Doyle</surname><given-names>D.</given-names></name><name><surname>Kearney</surname><given-names>D. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Rett syndrome: analysis of deaths in the British survey</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>6</volume>, <fpage>71</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="pmid">9452925</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>A. M.</given-names></name><name><surname>Julu</surname><given-names>P. O.</given-names></name></person-group> (<year>1999</year>). <article-title>Recent insights into hyperventilation from the study of Rett syndrome</article-title>. <source/>Arch. Dis. Child.
<volume>80</volume>, <fpage>384</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1136/adc.80.4.384</pub-id><pub-id pub-id-type="pmid">10086952</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishi</surname><given-names>N.</given-names></name><name><surname>Macklis</surname><given-names>J. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Dissecting MECP2 function in the central nervous system</article-title>. <source/>J. Child Neurol.
<volume>20</volume>, <fpage>753</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1177/08830738050200091001</pub-id><pub-id pub-id-type="pmid">16225831</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalley</surname><given-names>P. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Opioidergic and dopaminergic modulation of respiration</article-title>. <source/>Respir. Physiol. Neurobiol.
<volume>164</volume>, <fpage>160</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2008.02.004</pub-id><pub-id pub-id-type="pmid">18394974</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>J. D.</given-names></name><name><surname>Meehan</surname><given-names>R. R.</given-names></name><name><surname>Henzel</surname><given-names>W. J.</given-names></name><name><surname>Maurer-Fogy</surname><given-names>I.</given-names></name><name><surname>Jeppesen</surname><given-names>P.</given-names></name><name><surname>Klein</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title>Purification, sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA</article-title>. <source/>Cell
<volume>69</volume>, <fpage>905</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90610-o</pub-id><pub-id pub-id-type="pmid">1606614</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Pozzo-Miller</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>BDNF deregulation in Rett syndrome</article-title>. <source/>Neuropharmacology
<volume>76</volume>, <fpage>737</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.03.024</pub-id><pub-id pub-id-type="pmid">23597512</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lioy</surname><given-names>D. T.</given-names></name><name><surname>Garg</surname><given-names>S. K.</given-names></name><name><surname>Monaghan</surname><given-names>C. E.</given-names></name><name><surname>Raber</surname><given-names>J.</given-names></name><name><surname>Foust</surname><given-names>K. D.</given-names></name><name><surname>Kaspar</surname><given-names>B. K.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>A role for glia in the progression of Rett’s syndrome</article-title>. <source/>Nature
<volume>475</volume>, <fpage>497</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1038/nature10214</pub-id><pub-id pub-id-type="pmid">21716289</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maekawa</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Nakai</surname><given-names>D.</given-names></name><name><surname>Makino</surname><given-names>C.</given-names></name><name><surname>Takagi</surname><given-names>T.</given-names></name><name><surname>Ogura</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene</article-title>. <source/>EMBO J.
<volume>29</volume>, <fpage>196</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2009.318</pub-id><pub-id pub-id-type="pmid">19893493</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzke</surname><given-names>T.</given-names></name><name><surname>Guenther</surname><given-names>U.</given-names></name><name><surname>Ponimaskin</surname><given-names>E. G.</given-names></name><name><surname>Haller</surname><given-names>M.</given-names></name><name><surname>Dutschmann</surname><given-names>M.</given-names></name><name><surname>Schwarzacher</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>5-HT4<sub>a</sub> receptors avert opioid-induced breathing depression without loss of analgesia</article-title>. <source/>Science
<volume>301</volume>, <fpage>226</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1126/science.1084674</pub-id><pub-id pub-id-type="pmid">12855812</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzke</surname><given-names>T.</given-names></name><name><surname>Niebert</surname><given-names>M.</given-names></name><name><surname>Koch</surname><given-names>U. R.</given-names></name><name><surname>Caley</surname><given-names>A.</given-names></name><name><surname>Vogelgesang</surname><given-names>S.</given-names></name><name><surname>Hülsmann</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Serotonin receptor 1A-modulated phosphorylation of glycine receptor alpha3 controls breathing in mice</article-title>. <source/>J. Clin. Invest.
<volume>120</volume>, <fpage>4118</fpage>–<lpage>4128</lpage>. <pub-id pub-id-type="doi">10.1172/JCI43029</pub-id><pub-id pub-id-type="pmid">20978350</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthes</surname><given-names>H.</given-names></name><name><surname>Boschert</surname><given-names>U.</given-names></name><name><surname>Amlaiky</surname><given-names>N.</given-names></name><name><surname>Grailhe</surname><given-names>R.</given-names></name><name><surname>Plassat</surname><given-names>J. L.</given-names></name><name><surname>Muscatelli</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression and chromosomal localization</article-title>. <source/>Mol. Pharmacol.
<volume>43</volume>, <fpage>313</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="pmid">8450829</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellios</surname><given-names>N.</given-names></name><name><surname>Woodson</surname><given-names>J.</given-names></name><name><surname>Garcia</surname><given-names>R. I.</given-names></name><name><surname>Crawford</surname><given-names>B.</given-names></name><name><surname>Sharma</surname><given-names>J.</given-names></name><name><surname>Sheridan</surname><given-names>S. D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>111</volume>, <fpage>9947</fpage>–<lpage>9952</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1309426111</pub-id><pub-id pub-id-type="pmid">24958851</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesuret</surname><given-names>G.</given-names></name><name><surname>Dannenberg</surname><given-names>J.</given-names></name><name><surname>Arnoldt</surname><given-names>M.</given-names></name><name><surname>Grützner</surname><given-names>A.-A.</given-names></name><name><surname>Niebert</surname><given-names>M.</given-names></name><name><surname>Hülsmann</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Breathing disturbances in a model of Rett syndrome: a potential involvement of the glycine receptor alpha3 subunit?</article-title>
<source/>Respir. Physiol. Neurobiol.
<volume>248</volume>, <fpage>43</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2017.11.011</pub-id><pub-id pub-id-type="pmid">29203410</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mironov</surname><given-names>S. L.</given-names></name><name><surname>Skorova</surname><given-names>E. Y.</given-names></name><name><surname>Kügler</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Epac-mediated cAMP-signalling in the mouse model of Rett syndrome</article-title>. <source/>Neuropharmacology
<volume>60</volume>, <fpage>869</fpage>–<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.01.002</pub-id><pub-id pub-id-type="pmid">21232545</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>X.</given-names></name><name><surname>Campoy</surname><given-names>F. J.</given-names></name><name><surname>Bird</surname><given-names>A.</given-names></name></person-group> (<year>1997</year>). <article-title>MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin</article-title>. <source/>Cell
<volume>88</volume>, <fpage>471</fpage>–<lpage>481</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)81887-5</pub-id><pub-id pub-id-type="pmid">9038338</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niebert</surname><given-names>S.</given-names></name><name><surname>van Belle</surname><given-names>G. J.</given-names></name><name><surname>Vogelgesang</surname><given-names>S.</given-names></name><name><surname>Manzke</surname><given-names>T.</given-names></name><name><surname>Niebert</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>The serotonin receptor subtype 5b specifically interacts with serotonin receptor subtype 1A</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>:<fpage>299</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00299</pub-id><pub-id pub-id-type="pmid">28983239</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Ueda</surname><given-names>R.</given-names></name><name><surname>Togawa</surname><given-names>M.</given-names></name><name><surname>Ohmae</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Effect of serotonin 1A agonists and selective serotonin reuptake inhibitors on behavioral and nighttime respiratory symptoms in Rett syndrome</article-title>. <source/>Pediatr. Neurol.
<volume>60</volume>, <fpage>54.e1</fpage>–<lpage>59.e1</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2016.03.016</pub-id><pub-id pub-id-type="pmid">27212420</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penington</surname><given-names>N. J.</given-names></name><name><surname>Kelly</surname><given-names>J. S.</given-names></name><name><surname>Fox</surname><given-names>A. P.</given-names></name></person-group> (<year>1993</year>). <article-title>Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT<sub>1A</sub> receptors on dorsal raphe neurones of the adult rat</article-title>. <source/>J. Physiol.
<volume>469</volume>, <fpage>387</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1993.sp019819</pub-id><pub-id pub-id-type="pmid">8271204</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippe</surname><given-names>C.</given-names></name><name><surname>Villard</surname><given-names>L.</given-names></name><name><surname>De Roux</surname><given-names>N.</given-names></name><name><surname>Raynaud</surname><given-names>M.</given-names></name><name><surname>Bonnefond</surname><given-names>J. P.</given-names></name><name><surname>Pasquier</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update</article-title>. <source/>Eur. J. Med. Genet.
<volume>49</volume>, <fpage>9</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2005.04.003</pub-id><pub-id pub-id-type="pmid">16473305</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plassat</surname><given-names>J. L.</given-names></name><name><surname>Boschert</surname><given-names>U.</given-names></name><name><surname>Amlaiky</surname><given-names>N.</given-names></name><name><surname>Hen</surname><given-names>R.</given-names></name></person-group> (<year>1992</year>). <article-title>The mouse 5HT5 receptor reveals a remarkable heterogeneity within the 5HT<sub>1D</sub> receptor family</article-title>. <source/>EMBO J.
<volume>11</volume>, <fpage>4779</fpage>–<lpage>4786</lpage>. <pub-id pub-id-type="pmid">1464308</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>S.</given-names></name><name><surname>den Daas</surname><given-names>I.</given-names></name><name><surname>Foord</surname><given-names>S.</given-names></name><name><surname>Goodson</surname><given-names>S.</given-names></name><name><surname>Bull</surname><given-names>D.</given-names></name><name><surname>Kilpatrick</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Cloning and characterisation of the human 5-HT<sub>5A</sub> serotonin receptor</article-title>. <source/>FEBS Lett.
<volume>355</volume>, <fpage>242</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(94)01209-1</pub-id><pub-id pub-id-type="pmid">7988681</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>X.</given-names></name><name><surname>Funk</surname><given-names>G. D.</given-names></name><name><surname>Greer</surname><given-names>J. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Anxiety-related mechanisms of respiratory dysfunction in a mouse model of Rett syndrome</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>17230</fpage>–<lpage>17240</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2951-12.2012</pub-id><pub-id pub-id-type="pmid">23197715</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rett</surname><given-names>A.</given-names></name></person-group> (<year>1966</year>). <article-title>On a unusual brain atrophy syndrome in hyperammonemia in childhood</article-title>. <source/>Wien. Med. Wochenschr.
<volume>116</volume>, <fpage>723</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="pmid">5300597</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schüle</surname><given-names>B.</given-names></name><name><surname>Armstrong</surname><given-names>D. D.</given-names></name><name><surname>Vogel</surname><given-names>H.</given-names></name><name><surname>Oviedo</surname><given-names>A.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name></person-group> (<year>2008</year>). <article-title>Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure</article-title>. <source/>Clin. Genet.
<volume>74</volume>, <fpage>116</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.01005.x</pub-id><pub-id pub-id-type="pmid">18477000</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stettner</surname><given-names>G. M.</given-names></name><name><surname>Huppke</surname><given-names>P.</given-names></name><name><surname>Gärtner</surname><given-names>J.</given-names></name><name><surname>Richter</surname><given-names>D. W.</given-names></name><name><surname>Dutschmann</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Disturbances of breathing in Rett syndrome: results from patients and animal models</article-title>. <source/>Adv. Exp. Med. Biol.
<volume>605</volume>, <fpage>503</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1007/978-0-387-73693-8_88</pub-id><pub-id pub-id-type="pmid">18085325</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telgkamp</surname><given-names>P.</given-names></name><name><surname>Cao</surname><given-names>Y. Q.</given-names></name><name><surname>Basbaum</surname><given-names>A. I.</given-names></name><name><surname>Ramirez</surname><given-names>J.-M.</given-names></name></person-group> (<year>2002</year>). <article-title>Long-term deprivation of substance P in PPT-A mutant mice alters the anoxic response of the isolated respiratory network</article-title>. <source/>J. Neurophysiol.
<volume>88</volume>, <fpage>206</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1152/jn.2002.88.1.206</pub-id><pub-id pub-id-type="pmid">12091546</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viemari</surname><given-names>J.-C.</given-names></name></person-group> (<year>2008</year>). <article-title>Noradrenergic modulation of the respiratory neural network</article-title>. <source/>Respir. Physiol. Neurobiol.
<volume>164</volume>, <fpage>123</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2008.06.016</pub-id><pub-id pub-id-type="pmid">18634907</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viemari</surname><given-names>J.-C.</given-names></name><name><surname>Roux</surname><given-names>J.-C.</given-names></name><name><surname>Tryba</surname><given-names>A. K.</given-names></name><name><surname>Saywell</surname><given-names>V.</given-names></name><name><surname>Burnet</surname><given-names>H.</given-names></name><name><surname>Peña</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>11521</fpage>–<lpage>11530</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4373-05.2005</pub-id><pub-id pub-id-type="pmid">16354910</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogelgesang</surname><given-names>S.</given-names></name><name><surname>Niebert</surname><given-names>S.</given-names></name><name><surname>Renner</surname><given-names>U.</given-names></name><name><surname>Mobius</surname><given-names>W.</given-names></name><name><surname>Hulsmann</surname><given-names>S.</given-names></name><name><surname>Manzke</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Analysis of the serotonergic system in a mouse model of rett syndrome reveals unusual upregulation of serotonin receptor 5b</article-title>. <source/>Front. Mol. Neurosci.
<volume>10</volume>:<fpage>61</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00061</pub-id><pub-id pub-id-type="pmid">28337123</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegener</surname><given-names>E.</given-names></name><name><surname>Brendel</surname><given-names>C.</given-names></name><name><surname>Fischer</surname><given-names>A.</given-names></name><name><surname>Hülsmann</surname><given-names>S.</given-names></name><name><surname>Gärtner</surname><given-names>J.</given-names></name><name><surname>Huppke</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Characterization of the MeCP2R168X knockin mouse model for Rett syndrome</article-title>. <source/>PLoS One
<volume>9</volume>:<fpage>e115444</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0115444</pub-id><pub-id pub-id-type="pmid">25541993</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>